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Pregnancy duration and endometrial cancer risk: nationwide 
cohort study
Anders Husby,1,2 Jan Wohlfahrt,1 Mads Melbye1,3,4
ABSTRACT
OBJECTIVE
To explore the association between pregnancy 
duration and risk of endometrial cancer.
DESIGN
Nationwide register based cohort study.
SETTING
Denmark.
PARTICIPANTS
All Danish women born from 1935 to 2002.
MAIN OUTCOME MEASURES
Relative risk (incidence rate ratio) of endometrial 
cancer by pregnancy number, type, and duration, 
estimated using log-linear Poisson regression.
RESULTS
Among 2 311 332 Danish women with 3 947 650 
pregnancies, 6743 women developed endometrial 
cancer during 57 347 622 person years of follow-up. 
After adjustment for age, period, and socioeconomic 
factors, a first pregnancy was associated with a 
noticeably reduced risk of endometrial cancer, 
whether it ended in induced abortion (adjusted 
relative risk 0.53 (95% confidence interval 0.45 
to 0.64) or childbirth (0.66, 0.61 to 0.72). Each 
subsequent pregnancy was associated with an 
additional reduction in risk, whether it ended in 
induced abortion (0.81, 0.77 to 0.86) or childbirth 
(0.86, 0.84 to 0.89). Duration of pregnancy, age at 
pregnancy, spontaneous abortions, obesity, maternal 
birth cohort, fecundity, and socioeconomic factors did 
not modify the results.
CONCLUSIONS
The risk of endometrial cancer is reduced regardless 
of whether a pregnancy ends shortly after conception 
or at 40 weeks of gestation. This reduction in risk 
could be explained by a biological process occurring 
within the first weeks of pregnancy, as pregnancies 
ending in induced abortions were associated with 
similar reductions in risk as pregnancies ending in 
childbirth.
Introduction
Endometrial cancer is the most common gynaecological 
cancer in developed countries, with an increasing 
incidence in North America and Europe.1 2 A woman’s 
risk of endometrial cancer has been strongly associated 
with number of full term pregnancies, with a noticeable 
protection associated with the first full term pregnancy 
and additional protection associated with subsequent 
full term pregnancies.3-12 To date studies have focused 
little on the effect of the duration of pregnancy, and in 
particular shorter pregnancies (eg, induced abortions 
and preterm childbirths), in analysis of this protective 
factor.5 It is therefore unknown whether the protective 
association is driven by the ability to conceive (a 
woman’s fecundity), the cumulative number of months 
pregnant, or a process that occurs at a specific time 
during pregnancy.
We combined data from the nationwide Danish 
National Registry of Induced Abortions, the Medical 
Birth Registry, and the Danish Cancer Registry to 
investigate the association between pregnancy duration 
and risk of endometrial cancer. The nationwide cohort 
comprised 2.3 million women followed from January 
1978 to December 2014 who had more than 670 000 
induced abortions and 3.2 million births.
Methods
Population cohort
Since 1 April 1968 the Danish Civil Registration System 
has assigned a unique identification number to all 
Danish residents who were alive on that date or born 
thereafter. In addition, the register contains detailed 
personal information on all Danish residents, including 
linkage of women to their children’s dates of birth. 
Using the unique identification numbers, we created a 
population based cohort of all Danish women and their 
pregnancies by linking data from the Civil Registration 
System with data from the National Registry of Induced 
Abortions and the Medical Birth Registry.
Study variables
Since 1939 it has been mandatory in Denmark to 
report information on induced abortions to the 
National Registry of Induced Abortions, including 
the date of the procedure and the week of gestation. 
Induced abortions were only permitted for medical or 
other specified reasons until 1973. Thereafter, induced 
abortion until the end of the 12th week of gestation 
became legalised. Childbirths in Denmark, including 
dates of birth, have been registered since 1973 in the 
Medical Birth Registry, and gestational week at time of 
birth has been recorded from 1978.
From Statistics Denmark we acquired time varying, 
individual level socioeconomic data to address factors 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
The lifetime number of births is associated with a reduction in risk of endometrial 
cancer
The number of menstrual cycles suppressed by pregnancy has been suggested to 
be protective
WHAT THIS STUDY ADDS
This study found that the risk of endometrial cancer is reduced regardless of 
whether a woman’s pregnancy ends shortly after conception or at 40 weeks
This finding strongly suggests that factors early in gestation are responsible for 
the reduction in risk
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potentially associated with reproductive choices and 
cancer risk: educational attainment, marital status, 
and urbanicity (see supplementary appendix).
From the Danish National Patient Registry we 
acquired information on hospital diagnostic codes 
for obesity and non-malignant endometrial and 
ovarian diseases. We also obtained information on 
hysterectomies and bilateral oophorectomies, as 
registered by the Danish Classification of Surgical 
Procedures and Therapies from 1977 to 1995 and by 
the Nordic Medico-Statistical Committee Classification 
of Surgical Procedures from 1996 (see supplementary 
appendix). The Danish National Patient Registry 
also holds information on spontaneous abortions 
that resulted in clinical contact13 from 1977, but 
the registry does not hold detailed information on 
gestational week for these pregnancies.
Information on endometrial cancer and other 
cancer diagnoses was collected from the Danish 
Cancer Registry, which contains details on cancers 
diagnosed in Denmark since 1943 and is considered 
close to complete.14 Endometrial cancer was defined 
by ICD-10 (international classification of diseases, 
10th revision) codes C54-55 in combination with an 
endometrial cancer histological subtype by relevant 
ICD-O-3 (international classification of diseases for 
oncology, third edition) code (see supplementary 
appendix). Information on cancer stage (grouped 
using FIGO (International Federation of Gynecology 
and Obstetrics) classification15) and cancer subtype 
(by previously used grouping of subtype histology16) 
was also retrieved from the Danish Cancer Registry.
Participants
We established a cohort of all Danish women 
born between 1 January 1935 and 31 December 
2002. Using the Danish Civil Registration System 
identification number, we linked information on 
each woman’s pregnancies with the corresponding 
pregnancy type (ie, gestational week of every 
induced abortion) and duration (gestational week of 
delivery for every birth), and information on whether 
she developed endometrial cancer. Women were 
followed from 1 January 1978, or from their 12th 
birthday, whichever came later, until endometrial 
cancer, death, emigration, or 31 December 2014, 
whichever came first. We censored on cancer before 
start of follow-up, first diagnosis of any other cancer 
(excluding non-melanoma skin cancer), time of 
hysterectomy (including hystero-oophorectomy), and 
time of bilateral oophorectomy.
Statistical analyses
We used log-linear Poisson regression to estimate 
incidence rate ratios (relative risks) of endometrial 
cancer by pregnancy type. Analyses were adjusted for 
effects of attained age and time in five year categories, 
in addition to interaction between age and time. 
Analyses, except when otherwise stated, were adjusted 
for pregnancy history, educational attainment, marital 
status, and urbanicity, in addition to interaction 
between time and the three socioeconomic variables 
(see supplementary appendix).
Pregnancy history was modelled as described 
previously,17 with the effect of each pregnancy 
estimated as the effect of the pregnancy compared with 
one pregnancy less (ie, relative risk of endometrial 
cancer for one pregnancy compared with 0, two 
compared with one, three compared with two, and 
so on), where a pregnancy could result in either an 
induced abortion or birth. This parameterisation allows 
for a focus on the effect of each additional pregnancy. 
In additional analyses, we assumed relative risks to be 
the same for all pregnancies after the first pregnancy. 
To investigate whether the effect of induced abortions 
and childbirths varied by pregnancy duration (≤5 
weeks, 6-7 weeks, 8-9 weeks, 10-11 weeks, ≥12 weeks 
for induced abortions, and <37 weeks, ≥37 weeks for 
childbirths), age at pregnancy (<30 years, ≥30 years), 
time since pregnancy (<10 years, ≥10 years), and 
attained age (<50 years, ≥50 years), we allowed the 
relative risks to vary by these factors.
In sensitivity analyses we also considered potential 
confounding effects of obesity and oral contraceptives 
use. For this we investigated the effects of pregnancy 
on risk of endometrial cancer in subcohorts by clinical 
diagnosis of obesity and birth cohort, respectively.
Additionally, to investigate whether the effects of 
induced abortions and births were modified by previous 
induced abortions and births, we analysed the relative 
risk of endometrial cancer among parous women 
stratified by the number of induced abortions (0, 1, or 
≥2) and births (1, 2, 3, or ≥4). Uniparous women with 
no induced abortions were used as reference.
Finally, to explore potential effects of fecundity, we 
estimated the relative risk of endometrial cancer after 
a pregnancy (including both induced abortions and 
births) compared with one pregnancy less by age at 
and time since any pregnancy. In these analyses, age at 
pregnancy was stratified by less than 25 years, 25-29 
years, 30-34 years, and 35 or more years, whereas time 
since pregnancy was stratified by less than 10 years, 
10-19 years, 20-29 years, and 30 or more years. In 
addition, we created a high fecundity subcohort, which 
was defined as women with three or more pregnancies 
and a maximum of five years between their first and 
third pregnancy.
All tests were likelihood ratio tests. Analyses were 
performed using SAS procedure GENMOD.
Patient and public involvement
No patients were involved in setting the research 
question, outcome measures, the study design, or 
the conduct of the study. The results of the study will 
be disseminated to the public, patients, and health 
professionals by various media sources: press releases 
written using layman’s terms, social media postings, 
and scientific conferences.
Results
The cohort included 2 311 332 Danish women who 
were followed for 57 347 622 person years (average 
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of 24.8 years of follow-up per woman). The women 
had 3 947 650 pregnancies, of which 671 560 were 
induced abortions and 3 276 090 were births. The 
median gestational weeks of pregnancies that ended 
in induced abortion was 8 (interquartile range 7-9 
weeks), whereas the median gestational weeks of 
pregnancies that ended in birth was 40 (39-41 weeks). 
During follow-up, 6743 women developed endometrial 
cancer. Supplementary table S1 shows the number of 
endometrial cancer events and person years according 
to number of induced abortions, number of births, age 
at first pregnancy, age at latest pregnancy, duration 
of latest pregnancy, time since latest pregnancy, birth 
cohort, and socioeconomic factors.
Table 1 shows the relative risk of endometrial cancer 
after any pregnancy compared with one pregnancy 
less by type of pregnancy. We found that both induced 
abortions and births were associated with a reduced 
risk of endometrial cancer, with a particularly strong 
risk reduction after the first pregnancy (relative risk 
reduction around 40%). For the first pregnancy, 
an induced abortion was associated with a slightly 
larger risk reduction than a birth, but for subsequent 
pregnancies the association did not differ (P=0.25). 
However, for pregnancies taking place in the same 
period (from 1973 when induced abortion was 
legalised in Denmark), induced abortions and births 
were associated with the same risk reduction in 
endometrial cancer for both the first (P=0.50) and any 
subsequent pregnancy (P=0.41) (see supplementary 
table S2). The pattern was the same when stratifying 
further by duration of pregnancy (table 2).
When stratifying by age at pregnancy (table 3), 
no effect modification was found on the association 
between pregnancy type and endometrial cancer 
(P=0.69), when stratifying by time since pregnancy 
(table 3), no effect modification was found on the 
association between pregnancy type and endometrial 
cancer (P=0.94), and when stratifying by attained 
age (table 3), no effect modification was found on the 
association between pregnancy type and endometrial 
cancer (P=0.13). In addition, we performed analyses 
of the effect of pregnancy type on risk of endometrial 
cancer by cancer stage and subtype (table 4), by 
adjustment for non-malignant endometrial and 
ovarian disease (see supplementary table S3), and 
by degree of adjustment for socioeconomic factors 
(see supplementary table S4), and a similar pattern 
of no difference was observed in the association of 
induced abortions and births with risk of endometrial 
cancer. Nevertheless, for type II endometrial cancers 
no statistically significant reduction in risk was found 
by each additional pregnancy. This finding could be 
attributable to the limited number of cases of this 
cancer subtype.
We carried out an analysis limited to only parous 
women (≥1 birth), with uniparous women with no 
induced abortions as reference, to investigate the 
effect of number of childbirths stratified by number 
of induced abortions (fig 1). The results also indicate 
a protective effect on risk of endometrial cancer by 
both each additional childbirth and each additional 
induced abortion, in a dose-response manner.
Obesity is a strong risk factor for endometrial cancer. 
In a subcohort of 110 567 women who had been 
characterised as clinically obese in hospital registers 
(see supplementary table S5), no difference was 
found in the association between pregnancy type and 
risk of endometrial cancer (P=0.90), with estimates 
similar to those in the complete cohort. To explore a 
Table 1 | Relative risk of endometrial cancer after a pregnancy compared with having one pregnancy less by pregnancy 
number and type
Pregnancy No and type
Relative risk (95% CI)
Adjusted for age and period* Adjusted for age, period, and socioeconomic factors*†
First pregnancy
Induced abortion 0.52 (0.44 to 0.62) 0.53 (0.45 to 0.64)
Childbirth 0.66 (0.61 to 0.71) 0.66 (0.61 to 0.72)
Any subsequent
Induced abortion 0.80 (0.76 to 0.85) 0.81 (0.77 to 0.86)
Childbirth 0.88 (0.85 to 0.90) 0.86 (0.84 to 0.89)
Second pregnancy:
 Induced abortion 0.77 (0.66 to 0.90) 0.79 (0.67 to 0.92)
 Childbirth 0.85 (0.79 to 0.91) 0.83 (0.77 to 0.89)
Third pregnancy:
 Induced abortion 0.78 (0.70 to 0.87) 0.80 (0.71 to 0.89)
 Childbirth 0.86 (0.80 to 0.92) 0.84 (0.78 to 0.90)
Fourth pregnancy:
 Induced abortion 0.81 (0.70 to 0.94) 0.82 (0.71 to 0.95)
 Childbirth 0.92 (0.81 to 1.04) 0.91 (0.80 to 1.03)
Fifth pregnancy:
 Induced abortion 0.81 (0.63 to 1.03) 0.81 (0.63 to 1.04)
 Childbirth 0.92 (0.72 to 1.16) 0.91 (0.72 to 1.16)
*Adjusted for age, period, pregnancy history, and interaction between age and period.
†Additionally adjusted for educational attainment, marital status, urbanicity, and interaction between period and educational attainment, marital status, 
and urbanicity, respectively. P value for difference between induced abortion and childbirth for risk of endometrial cancer, adjusted for age, period, 
and socioeconomic factors, are 0.07 (relative risk 0.53 v 0.66) and 0.25 (0.81 v 0.86), respectively, for first and any subsequent pregnancy. Test for 
difference between model with different effect of each pregnancy compared with model with same effect for all pregnancies after the first pregnancy gave 
P=0.99. Sensitivity analysis with start of follow-up from 20 years of age presented in supplementary table S9 gave identical results.
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potential confounding effect of oral contraceptive 
use, the association between pregnancy type and 
risk of endometrial cancer was investigated among 
women from several birth cohorts, with different 
possible lifetime use of oral contraceptive use (see 
supplementary table S6). No difference was found in 
the association by birth cohort. Furthermore, when 
information on spontaneous abortions available from 
1977 was included (see supplementary table S7), the 
association between induced abortions and births and 
risk of endometrial cancer was not modified (P=0.08).
Lastly, to explore the potential effects of fecundity, 
we investigated the association between any pregnancy 
(including both induced abortions and childbirths) and 
risk of endometrial cancer. The protective association 
between pregnancy and risk of endometrial cancer 
was more pronounced for pregnancies at an older age 
(see supplementary fig S1A) and shorter time since 
pregnancy (see supplementary fig S1B), with any 
subsequent pregnancy associated with an 11% (95% 
confidence interval 6% to 15%) risk reduction before 
age 25 compared with 25% (20% to 30%) after age 35, 
and with a 52% (43% to 60%) risk reduction within 
the first 10 years after pregnancy compared with a 
10% (7% to 13%) risk reduction after 30 or more years. 
In a high fecundity subcohort consisting of women 
with three or more pregnancies who had less than 
five years between their first and third pregnancy (see 
supplementary table S8), an additional pregnancy had 
a similar effect to that in other women also with three 
pregnancies.
Discussion
In a nationwide cohort study of pregnancy duration 
and risk of endometrial cancer, using information 
from 2.3 million women with more than 670 000 
induced abortions and 3.2 million childbirths, a 
strong protective association was found between 
first pregnancy and risk of endometrial cancer, with 
additional protection from each subsequent pregnancy. 
The protective association was equivalent for induced 
abortions and childbirths.
Possible explanation for findings
Our findings contrast with the current understanding 
of the cause of endometrial cancer, which is centred 
around the unopposed oestrogens hypothesis, 
whereby the risk of endometrial cancer increases 
with number of menstrual years (from menarche to 
menopause) and decreases with years of pregnancy 
and oral contraceptive use.7 10 18 19 20 However, a 
study found that each additional year of pregnancy 
was associated with a 22% risk reduction in risk of 
endometrial cancer, whereas both each additional 
year of oral contraceptive use and each year of delayed 
menarche or advanced menopause were associated 
with only around an 8% risk reduction,5 indicating 
that a pregnancy affects a woman’s risk of endometrial 
cancer through a different mechanism than number of 
menstrual years.
Two underlying mechanisms could explain our 
finding. Foremost, the association could be due to a 
fecundity effect, whereby the number of pregnancies is 
a proxy for a woman’s ability to become pregnant, and 
thereby a healthy endometrium and endocrine system. 
Several observations argue against this idea however. 
Table 3 | Relative risk of endometrial cancer after a pregnancy compared with having 
one pregnancy less by pregnancy number and type, stratified by age at pregnancy, time 
since pregnancy, and attained age at diagnosis
Pregnancy No and type Adjusted relative risk (95% CI)*
Age at pregnancy† <30 years ≥30 years
First pregnancy:
 Induced abortion 0.59 (0.48 to 0.72) 0.42 (0.30 to 0.61)
 Childbirth 0.67 (0.62 to 0.73) 0.61 (0.55 to 0.69)
Any subsequent:
 Induced abortion 0.90 (0.80 to 1.01) 0.78 (0.73 to 0.84)
 Childbirth 0.89 (0.86 to 0.92) 0.79 (0.75 to 0.83)
Time since pregnancy‡ <10 years ≥10 years
First pregnancy:
 Induced abortion 0.36 (0.13 to 0.97) 0.56 (0.47 to 0.67)
 Childbirth 0.33 (0.23 to 0.50) 0.68 (0.62 to 0.73)
Any subsequent:
 Induced abortion 0.45 (0.32 to 0.62) 0.84 (0.79 to 0.89)
 Childbirth 0.45 (0.36 to 0.56) 0.87 (0.84 to 0.90)
Attained age§ <50 years ≥50 years
First pregnancy:
 Induced abortion 0.40 (0.28 to 0.56) 0.61 (0.49 to 0.75)
 Childbirth 0.42 (0.35 to 0.51) 0.73 (0.67 to 0.80)
Any subsequent:
 Induced abortion 0.80 (0.68 to 0.94) 0.82 (0.77 to 0.87)
 Childbirth 0.73 (0.67 to 0.81) 0.88 (0.85 to 0.91)
*Adjusted for age, period, educational attainment, marital status, urbanicity, and interaction between period and 
age, educational attainment, marital status, and urbanicity, respectively. Test for difference in fit when stratifying 
by age at pregnancy, time since pregnancy, and attained age, respectively, compared with analysis in table 1, 
P=0.69, P=0.94, and P=0.13, respectively.
†5215 events and 32 745 464 person years among women with a pregnancy before age 30 years, and 2462 
events and 15 465 953 person years among women with a pregnancy at or after age 30 years.
‡123 events and 16 813 543 person years among women with less than 10 years since pregnancy, and 5681 
events and 26 026 430 person years among women with less than 10 years since pregnancy.
§929 events and 46 156 519 person years among women aged less than 50 years, and 5814 events and 
11 191 103 person years among women aged 50 or more years.
Table 2 | Relative risk of endometrial cancer after a pregnancy compared with having one 
pregnancy less by pregnancy number and type, stratified by weeks of gestation
Pregnancy No, type, and duration Adjusted relative risk (95% CI)*
First pregnancy†
Induced abortion (weeks):
 ≤5 0.66 (0.30 to 1.48)
 6-7 0.56 (0.43 to 0.73)
 8-9 0.54 (0.41 to 0.70)
 10-11 0.46 (0.29 to 0.71)
 ≥12 0.59 (0.24 to 1.41)
Childbirth (weeks):
 ≤36 0.61 (0.44 to 0.85)
 ≥37 0.49 (0.43 to 0.55)
Any subsequent†
Induced abortion (weeks):
 ≤5 0.71 (0.49 to 1.02)
 6-7 0.75 (0.68 to 0.83)
 8-9 0.84 (0.76 to 0.92)
 10-11 0.93 (0.80 to 1.08)
 ≥12 0.81 (0.51 to 1.28)
Childbirth (weeks):
 ≤36 0.87 (0.70 to 1.10)
 ≥37 0.73 (0.69 to 0.78)
*Adjusted for age, period, educational attainment, marital status, urbanicity, and interaction between period and 
age, educational attainment, marital status, and urbanicity, respectively.
†Test for difference in fit when stratifying by gestational duration of pregnancy as in table 2, compared with 
stratification only by pregnancy type as in table 1, P=0.98.
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Firstly, we found no difference in the effect of a woman’s 
second to fifth pregnancy, with each pregnancy having 
a similar protective effect, rather than a trend whereby 
each additional pregnancy was associated with a lower 
risk reduction for endometrial cancer. Secondly, when 
we examined the effect of an additional pregnancy in 
our high fecundity subcohort, the association between 
an additional pregnancy and risk of endometrial 
cancer was similar to that among other women with 
the same number of pregnancies. Finally, a large 
collaborative study from the Endometrial Cancer 
Consortium EC2C found a strong protective effect of 
parity even after adjusting for self reported infertility,11 
which also argues against fecundity explaining the 
association between number of pregnancies and risk 
of endometrial cancer. Taken together, these findings 
point to an early gestational effect, present in the 
first weeks after conception, to be the most likely 
underlying mechanism responsible for the protective 
effect of pregnancy on risk of endometrial cancer.
A plausible explanation for an early gestational 
effect is the rapid increase of the progesterone to 
oestrogen ratio in the first weeks after conception, when 
progesterone levels increase more than threefold and 
oestrogen levels increase only modestly.21 In support 
of this hypothesis, the Norwegian Women and Cancer 
(NOWAC) prospective cohort study of 104 318 women 
recently found that the risk of endometrial cancer in 
ever users of progesterone intrauterine devices (LNG-
IUS) was only 22% (95% confidence interval 13% to 
40%) compared with never users in a multivariable 
analysis adjusted for oral contraceptive use, parity, 
body mass index, and other potential confounders.22 
In addition, multiple studies have found a favourable 
effect of progesterone treatment for both endometrial 
hyperplasia—a precursor for endometrial cancer—and 
low stage endometrial cancer.23 24
Strengths and limitations of this study
We used a Danish nationwide cohort design with 
follow-up spanning four decades. Furthermore, 
given our access to prospectively registered clinical 
information on both induced abortions and births 
(including duration of pregnancy), we avoid recall bias, 
which is known to introduce biases when investigating 
the effects of induced abortion.25
We also investigated the effect of potential important 
confounders such as obesity, birth cohort, marital 
status, educational attainment, and urbanicity, and 
found no indications of confounding on the association 
Table 4 | Relative risk of endometrial cancer after a pregnancy compared with having one pregnancy less by pregnancy 
number and type, by cancer stage and cancer subtype*
Pregnancy No and type
Adjusted relative risk (95% CI)†
Cancer stage‡ Cancer subtype§
Stage I Stage II-IV Type I Type II
No of events 2968 1021 6203 485
First pregnancy:
 Induced abortion 0.51 (0.40 to 0.64) 0.73 (0.53 to 1.02) 0.53 (0.44 to 0.63) 0.70 (0.38 to 1.31)
 Childbirth 0.70 (0.62 to 0.79) 0.63 (0.52 to 0.76) 0.67 (0.61 to 0.72) 0.62 (0.45 to 0.87)
Any subsequent:
 Induced abortion 0.86 (0.80 to 0.93) 0.80 (0.70 to 0.91) 0.81 (0.76 to 0.86) 0.84 (0.68 to 1.03)
 Childbirth 0.89 (0.85 to 0.93) 0.91 (0.84 to 0.97) 0.84 (0.82 to 0.87) 1.09 (0.98 to 1.21)
*Analyses by competing risks between stage/subtype groups and other cancers.
†Adjusted for age, period, educational attainment, marital status, urbanicity, and interaction between period and age, educational attainment, marital 
status, and urbanicity, respectively.
‡Analysis of cancer stage included 19 721 829 person years and was based on follow-up time from 2004. Missing stage and low stage were grouped 
together. Sensitivity analysis on cancer stage based events only after implementation of the 2009 FIGO revision of stage is presented in supplementary 
table S10.
§Analysis of cancer subtype included 57 348 802 person years and was based on follow-up time from 1978. The few endometrial cancers not grouped in 
type I and type II was included in the analysis as a separate outcome (see supplementary methods for definitions of endometrial cancer subtypes).
No of childbirths
0 induced abortions
    Events
    Person years (000s)
1 induced abortion
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    Person years (000s)
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Fig 1 | Relative risk of endometrial cancer among parous women (≥1 birth) by number 
of induced abortions and births, with uniparous women with no induced abortions 
as reference. Estimates are adjusted for age, period, educational attainment, marital 
status, urbanicity, and interaction between period and age, educational attainment, 
marital status, and urbanicity, respectively. Events and person years (in 1000s) are 
given for each number of induced abortion and birth. Test for interaction between 
induced abortions and births, P=0.92
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between pregnancy duration and risk of endometrial 
cancer. However, we did not have information on 
lifetime use of oral contraceptives, which has been 
associated with a decreased risk of endometrial 
cancer 26 and potentially could explain the association 
between induced abortions and reduced risk of 
endometrial cancer. Nevertheless, two findings argue 
against this assumption. Firstly, we found no difference 
in the effect of induced abortion and childbirth on risk 
of endometrial cancer in different birth cohorts (see 
supplementary table S6), despite different possible 
lifetime use of oral contraceptives, which were 
available in Denmark from 1966 (see supplementary 
fig S2). Secondly, most of the previous studies on 
endometrial cancer that adjusted for oral contraceptive 
use found indications of a risk reducing effect of 
induced abortions on risk of endometrial cancer.4 6 7 9 10 
Furthermore, our estimates of the pregnancy effect on 
risk of endometrial cancer were more similar when 
we focused on pregnancies in the same period (see 
supplementary table S2). This observation suggests 
that the marginally smaller risk reduction by births 
compared with induced abortions (table 1) likely is 
explained by confounding from oral contraceptive 
use, as a proportion of the births occurred before the 
introduction of oral contraceptives.
Spontaneous abortions were associated with less 
reduction in risk of endometrial cancer than induced 
abortions and births. However, spontaneous abortions 
represent a heterogeneous group of unhealthy pre-
gnancies in contrast with induced abortions and 
births, which primarily are healthy pregnancies. In 
addition, studies report that pregnancies resulting in 
spontaneous abortion have low levels of gestational 
hormones (including progesterone),27 28 which could 
explain the weaker association between spontaneous 
abortions and risk of endometrial cancer.
Conclusions and implications
Our study shows that the protective association between 
pregnancy and endometrial cancer is equivalent for 
pregnancies resulting in induced abortion and birth, 
and thus suggests that the association is attributable to 
a woman’s underlying fecundity or a biological process 
occurring early in gestation. The findings from our 
study and others support an early gestational process, 
as each additional pregnancy was associated with a 
reduction in risk of endometrial cancer, and because 
adjustment for infertility did not explain the effect of 
parity on risk. Future research is of great importance 
as it could lead to insights into early gestational factors 
that potentially could facilitate the prevention of 
endometrial cancer.
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